Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03914235
Other study ID # R-2018-1301-021
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date August 1, 2018
Est. completion date April 8, 2019

Study information

Verified date April 2019
Source Instituto Mexicano del Seguro Social
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The aim of this study is to evaluate the effectiveness of the tumescent anesthesia technique in the surgical management of hand tenosynovitis. For this, an open clinical trial was conducted, which included patients with hand tenosynovitis (carpal tunnel syndrome, trigger finger and Quervain syndrome), which were randomly assigned to a group. The control group was released pulleys and ligaments with local anesthetic technique and hemostasis with pneumatic tourniquet; While the study group was released from the pulleys and ligaments with tumescent anesthesia. The study variables were: anesthesia time, trans-surgical bleeding, pain, total procedure time and tissue reperfusion time.


Description:

Introduction: The WALANT technique (Wide Awake Local Anesthesia No-Torniquet) proposes the use of local anesthesia, epinephrine and tourniquet in the areas of the hand to be repaired, making costs and time and comfort more efficient.

Objective: Evaluation of the effectiveness of the WALANT technique versus regional anesthesia with tourniquet in pain control, surgical management of stenosing tenosynovitis.

Material and methods: Open clinical trial including patients with the trigger finger, tunnel syndrome in the operating room, candidates for surgery, and excluding previous surgeries at the site of the injury, hemodynamic instability, peripheral vascular diseases, smoking, anxiety, or psychiatric diseases. The anesthetic method was applied to the incision sites according to the diagnosis and the proposed procedure. At the end of the test, tumescent solution and control, 1% lidocaine plus pneumatic tourniquet on the forearm at 250mmHg. The main variables were: type of anesthesia and pain during the procedure. Descriptive and inferential statistics were applied (xi2, t-student or Mann-Whitney U).


Recruitment information / eligibility

Status Completed
Enrollment 60
Est. completion date April 8, 2019
Est. primary completion date March 31, 2019
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Right holders of the Mexican Social Security Institute

- Over 18 years

- Trigger Finger Diagnosis

- Diagnosis of Carpal Tunnel Syndrome

- Diagnosis of Quervain Syndrome

- Acceptance and signature of informed consent

Exclusion Criteria:

- Necessity for concomitant surgery

- Previous surgeries on the injured site

- Hemodynamic instability

- History of peripheral vascular diseases

- Do not wish to participate in the study

- Hypersensitivity to medication

- Smoking

Study Design


Related Conditions & MeSH terms


Intervention

Combination Product:
Tumescent Anesthesia
A tumescent solution is prepared with 2% lidocaine (10ml), 1:1000 epinephrine (0.4ml) and 7.5% sodium bicarbonate (4ml) dissolved in 0.9% saline solution (40ml) and applied from 3 to 20ml (depending on the pathology to be repaired) at the incision site.
Drug:
Lidocaine
Apply 3 to 20 ml at the incision site, depending on the pathology to be repaired(carpal tunnel syndrome, trigger finger or Quervain syndrome).
Device:
Pneumatic tourniquet
Level of the forearm at 250 mmHg, after exsanguination with Esmarch bandage.
Procedure:
Open release of the tendon
Standard surgical procedure for carpal tunnel syndrome, trigger finger and Quervain syndrome.

Locations

Country Name City State
Mexico Western Medical Center, Mexican Institute of Social Security Guadalajara Jalisco

Sponsors (1)

Lead Sponsor Collaborator
Instituto Mexicano del Seguro Social

Country where clinical trial is conducted

Mexico, 

Outcome

Type Measure Description Time frame Safety issue
Primary Procedure pain: Visual Analog Scale Evaluated by Visual Analog Scale, A subjective psychometric response scale used to measure distinct behavioral or physiological phenomena based on linear numerical gradient, with values from 0 to 10. In the value 0 the absence or less intensity is located and in 10 the greater intensity of pain. immediate post surgery
Secondary Bleeding Bleeding estimated in consensus between anesthesiologist and surgeon, based on the gauze used during surgery immediate post surgery
Secondary Anesthesia application time The interval of time in minutes that is required to apply the anesthetic method chosen in the area to be used at the beginning of the application of anesthesia
See also
  Status Clinical Trial Phase
Terminated NCT03704584 - Corticosteroid(CS) + Lido or Corticosteroid(CS) Alone Phase 4
Recruiting NCT02320929 - The Treatment of Purulent Flexor Tenosynovitis N/A
Completed NCT03792945 - Comparison of the Efficacy of Corticosteroid Injection and ESWT in Patients With CTS Phase 4
Completed NCT01424995 - The Natural History of Congenital Trigger Thumbs
Terminated NCT02266433 - Dexamethasone Versus Ketorolac Injection for the Treatment of Local Inflammatory Hand and Upper Extremity Disorders Phase 3